Company intelligence / Profile preview

Brann

Zwingenberg, Hesse, Germanybrann.no ↗

Ownership: Private
Employees: ~330
Development stage: Other

Overview

BRAIN Biotech develops innovative solutions in industrial biotechnology with a focus on specialty enzymes and microbial production strains. The company provides contract R&D services to various industries including pharmaceuticals but does not have its own clinical drug pipeline or results.

Therapeutic areas: Other
Modalities: EnzymeProteinMicrobial production strain
Industry: Non-Drug Biotech

Partnerships

Notable partnerships with Royalty Pharma for monetization of licensing rights to investigational compound Deucrictibantnumerous collaborations with industry partners through CRO services

Beyond the preview

Go deeper on Brann.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brann.

Explore the full profile